Search research articles
Contact Us
Filters
Showing results (151-160 of 272) with videos related to
Page
of 28
Sort By:
Blood
|
May 27, 2004
Adenovirus-mediated intralesional interferon-gamma gene transfer induces tumor regressions in cutaneous lymphomas
Reinhard Dummer, Jessica C Hassel, Friederike Fellenberg, et al.
Cancers
|
November 11, 2022
Reinduction of Hedgehog Inhibitors after Checkpoint Inhibition in Advanced Basal Cell Carcinoma: A Series of 12 Patients
Viola K DeTemple, Jessica C Hassel, Michael M Sachse, et al.
Cancer Treatment Reviews
|
August 1, 2020
Melanoma brain metastases - Interdisciplinary management recommendations 2020
Ralf Gutzmer, Dirk Vordermark, Jessica C Hassel, et al.
Cancers
|
March 14, 2026
Mycophenolate Mofetil for Treatment of Ipilimumab-Induced Colitis in Patients with Metastatic Melanoma
Christina Naoum, Julia K Winkler, Pawel Majenka, et al.
The Oncologist
|
May 9, 2026
Selective internal radiotherapy and chemosaturation show equivalent survival in metastatic uveal melanoma: a retrospective multicenter study
Elias A T Koch, Louisa A Schielein, Markus Reitmajer, et al.
The Journal of Investigative Dermatology
|
December 11, 2012
Chemovirotherapy of malignant melanoma with a targeted and armed oncolytic measles virus
Johanna K Kaufmann, Sascha Bossow, Christian Grossardt, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 13, 2024
The RANKL inhibitor denosumab in combination with dual checkpoint inhibition is associated with increased CXCL-13 serum concentrations
Katrin Schaper-Gerhardt, Ralf Gutzmer, Yenny Angela, et al.
Deutsches Arzteblatt International
|
April 3, 2024
An Online Decision Aid for Patients With Metastatic Melanoma—Results of the Randomized Controlled Trial “PEF-Immun”
Pia Grabbe, Milena S Borchers, Kathrin M Gschwendtner, et al.
Journal for Immunotherapy of Cancer
|
September 20, 2023
Sex and anti-inflammatory treatment affect outcome of melanoma and non-small cell lung cancer patients with rheumatic immune-related adverse events
Karolina Gente, Leonore Diekmann, Lea Daniello, et al.
European Journal of Cancer (Oxford, England : 1990)
|
February 20, 2017
Programmed cell death protein-1 (PD-1) inhibitor therapy in patients with advanced melanoma and preexisting autoimmunity or ipilimumab-triggered autoimmunity
Ralf Gutzmer, Anika Koop, Friedegund Meier, et al.
Page
of 28
Search research articles
Search
Showing results (151-160 of 272) with videos related to
Sort By:
Page
of 28
Blood
|
May 27, 2004
Adenovirus-mediated intralesional interferon-gamma gene transfer induces tumor regressions in cutaneous lymphomas
Reinhard Dummer, Jessica C Hassel, Friederike Fellenberg, et al.
Cancers
|
November 11, 2022
Reinduction of Hedgehog Inhibitors after Checkpoint Inhibition in Advanced Basal Cell Carcinoma: A Series of 12 Patients
Viola K DeTemple, Jessica C Hassel, Michael M Sachse, et al.
Cancer Treatment Reviews
|
August 1, 2020
Melanoma brain metastases - Interdisciplinary management recommendations 2020
Ralf Gutzmer, Dirk Vordermark, Jessica C Hassel, et al.
Cancers
|
March 14, 2026
Mycophenolate Mofetil for Treatment of Ipilimumab-Induced Colitis in Patients with Metastatic Melanoma
Christina Naoum, Julia K Winkler, Pawel Majenka, et al.
The Oncologist
|
May 9, 2026
Selective internal radiotherapy and chemosaturation show equivalent survival in metastatic uveal melanoma: a retrospective multicenter study
Elias A T Koch, Louisa A Schielein, Markus Reitmajer, et al.
The Journal of Investigative Dermatology
|
December 11, 2012
Chemovirotherapy of malignant melanoma with a targeted and armed oncolytic measles virus
Johanna K Kaufmann, Sascha Bossow, Christian Grossardt, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 13, 2024
The RANKL inhibitor denosumab in combination with dual checkpoint inhibition is associated with increased CXCL-13 serum concentrations
Katrin Schaper-Gerhardt, Ralf Gutzmer, Yenny Angela, et al.
Deutsches Arzteblatt International
|
April 3, 2024
An Online Decision Aid for Patients With Metastatic Melanoma—Results of the Randomized Controlled Trial “PEF-Immun”
Pia Grabbe, Milena S Borchers, Kathrin M Gschwendtner, et al.
Journal for Immunotherapy of Cancer
|
September 20, 2023
Sex and anti-inflammatory treatment affect outcome of melanoma and non-small cell lung cancer patients with rheumatic immune-related adverse events
Karolina Gente, Leonore Diekmann, Lea Daniello, et al.
European Journal of Cancer (Oxford, England : 1990)
|
February 20, 2017
Programmed cell death protein-1 (PD-1) inhibitor therapy in patients with advanced melanoma and preexisting autoimmunity or ipilimumab-triggered autoimmunity
Ralf Gutzmer, Anika Koop, Friedegund Meier, et al.
Page
of 28